Literature DB >> 33617511

A Critical Appraisal of Evidence- and Consensus-Based Guidelines for Actinic Keratosis.

Anja Wessely1,2, Theresa Steeb1,2, Franz Heppt1,2, Annkathrin Hornung1,2, Matthias D Kaufmann1,2, Elias A T Koch1,2, Frédéric Toussaint1,2, Michael Erdmann1,2, Carola Berking1,2, Markus V Heppt1,2.   

Abstract

Actinic keratoses (AK) are common lesions of the skin that can be effectively treated with several lesion- and field-directed treatments. Clinical practice guidelines assist physicians in choosing the appropriate treatment options for their patients. Here, we aimed to systematically identify and evaluate the methodological quality of currently available guidelines for AK. Guidelines published within the last 5 years were identified in a systematic search of guideline databases, Medline and Embase. Then, six independent reviewers evaluated the methodological quality using the tools "Appraisal of Guidelines for Research and Evaluation" (AGREE II) and "Recommendation EXcellence" (AGREE-REX). The Kruskal-Wallis (H) test was used to explore differences among subgroups and Spearman's correlation to examine the relationship between individual domains. Three guidelines developed by consortia from Canada, Germany and the United Kingdom were eligible for the evaluation. The German guideline achieved the highest scores, fulfilling 65 to 92% of the criteria in AGREE II and 67 to 84% in AGREE-REX, whereas the Canadian guideline scored 31 to 71% of the criteria in AGREE II and 33 to 46% in AGREE-REX. The domains "stakeholder involvement" and "values and preferences" were identified as methodological weaknesses requiring particular attention and improvement in future guideline efforts.

Entities:  

Keywords:  AGREE; actinic keratosis; level of evidence; practice guideline; solar keratosis

Mesh:

Year:  2021        PMID: 33617511      PMCID: PMC7985770          DOI: 10.3390/curroncol28010093

Source DB:  PubMed          Journal:  Curr Oncol        ISSN: 1198-0052            Impact factor:   3.677


  24 in total

Review 1.  AGREE II: advancing guideline development, reporting and evaluation in health care.

Authors:  Melissa C Brouwers; Michelle E Kho; George P Browman; Jako S Burgers; Francoise Cluzeau; Gene Feder; Béatrice Fervers; Ian D Graham; Jeremy Grimshaw; Steven E Hanna; Peter Littlejohns; Julie Makarski; Louise Zitzelsberger
Journal:  CMAJ       Date:  2010-07-05       Impact factor: 8.262

2.  Efficacy of photodynamic therapy combined with topical interventions for the treatment of actinic keratosis: a meta-analysis.

Authors:  M V Heppt; T Steeb; U Leiter; C Berking
Journal:  J Eur Acad Dermatol Venereol       Date:  2019-03-01       Impact factor: 6.166

3.  Cryosurgery combined with topical interventions for actinic keratosis: a systematic review and meta-analysis.

Authors:  M V Heppt; T Steeb; T Ruzicka; C Berking
Journal:  Br J Dermatol       Date:  2018-12-27       Impact factor: 9.302

Review 4.  A critical appraisal of evidence-based guidelines for the treatment of psoriasis vulgaris: 'AGREE-ing' on a common base for European evidence-based psoriasis treatment guidelines.

Authors:  A Nast; P H Spuls; A D Ormerod; N Reytan; P H Saiag; C H Smith; B Rzany
Journal:  J Eur Acad Dermatol Venereol       Date:  2009-02-28       Impact factor: 6.166

5.  Actinic keratoses: Natural history and risk of malignant transformation in the Veterans Affairs Topical Tretinoin Chemoprevention Trial.

Authors:  Vincent D Criscione; Martin A Weinstock; Mark F Naylor; Claudia Luque; Melody J Eide; Stephen F Bingham
Journal:  Cancer       Date:  2009-06-01       Impact factor: 6.860

Review 6.  Italian expert consensus for the management of actinic keratosis in immunocompetent patients.

Authors:  K Peris; P G Calzavara-Pinton; L Neri; G Girolomoni; G Malara; A Parodi; S Piaserico; R Rossi; G Pellacani
Journal:  J Eur Acad Dermatol Venereol       Date:  2016-04-06       Impact factor: 6.166

Review 7.  Ingenol mebutate: a new option for actinic keratosis treatment.

Authors:  J Gras
Journal:  Drugs Today (Barc)       Date:  2013-01       Impact factor: 2.245

Review 8.  The more the better? An appraisal of combination therapies for actinic keratosis.

Authors:  T Steeb; A Wessely; U Leiter; L E French; C Berking; M V Heppt
Journal:  J Eur Acad Dermatol Venereol       Date:  2019-11-11       Impact factor: 6.166

9.  The Quality of Practice Guidelines for Melanoma: A Methodologic Appraisal with the AGREE II and AGREE-REX Instruments.

Authors:  Theresa Steeb; Anja Wessely; Konstantin Drexler; Martin Salzmann; Frédéric Toussaint; Lucie Heinzerling; Markus Reinholz; Carola Berking; Markus V Heppt
Journal:  Cancers (Basel)       Date:  2020-06-18       Impact factor: 6.639

10.  Treatment Motivations and Expectations in Patients with Actinic Keratosis: A German-Wide Multicenter, Cross-Sectional Trial.

Authors:  Theresa Steeb; Anja Wessely; Dagmar von Bubnoff; Thomas Dirschka; Konstantin Drexler; Conrad Falkenberg; Jessica C Hassel; Kinan Hayani; Svea Hüning; Katharina C Kähler; Sigrid Karrer; Christian Krammer; Ulrike Leiter; Diana Lill; Enklajd Marsela; Andreas Meiwes; Dorothée Nashan; Suzan Nasifoglu; Lutz Schmitz; Judith Sirokay; Alexander Thiem; Jochen Utikal; Alexander Zink; Carola Berking; Markus V Heppt
Journal:  J Clin Med       Date:  2020-05-12       Impact factor: 4.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.